Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial

Monday, April 25, 2022 1 min read

Key Takeaway: Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial

Full Press Release Details

Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial.